Global Oncologists Market Segments 2024, Forecast To 2033
5 Mar, 2024
The oncologists market has demonstrated steady growth, rising from $19.35 billion in 2023 to $19.79 billion in 2024, with a 2.3% CAGR. Historical growth is linked to increasing cancer incidence, therapeutic advancements, aging population, healthcare infrastructure development, and awareness programs. Expecting steady growth, the market is projected to reach $22.72 billion in 2028, with a 3.5% CAGR. Key forecasted trends include immunotherapy advancements, precision medicine integration, telemedicine expansion, data-driven decision-making, collaborative care models, and patient-centric care.
Global Oncologists Market Key Driver
The oncologists' market expands with the growing prevalence of cancer, demonstrated by a 43% increase in new cancer cases from 2019 to 2020. The rise in cancer cases drives demand for specialized healthcare professionals, fostering market growth.
Get A Free Sample Of The Global Oncologists Market ReportGlobal Oncologists Market Segments
The oncologists market covered in this report is segmented –
1) By Cancer Diagnostics and Treatment: Cancer Diagnostics, Cancer Treatment
2) By Indication: Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head and Neck Cancer, Prostate Cancer, Other Indications
3) By End Use: Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Specialty Clinics, Academia, Other End Uses
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the oncologists market in 2023. The regions covered in the oncologists market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Oncologists Industry Players
Abramson Cancer Center; MD Anderson Cancer Center of the University of Texas; Lilavati Hospital & Research Centre; Mount Elizabeth Hospital; Mount Miriam Cancer Hospital; Charité - Universitätsmedizin Berlin; General Electric Healthcare; F. Hoffmann-La Roche AG; Pfizer Inc.; Bayer AG; Merck & Co. Inc.; Aegerion Pharmaceuticals Inc.; AbbVie Inc.; Amgen Inc.; Takeda Pharmaceuticals USA Inc.; Becton Dickinson and Company; Cook Medical LLC; Terumo Corporation; AngioDynamics Inc.; Thermo Fisher Scientific Inc.; Illumina Inc.; Bristol-Myers Squibb Company; AstraZeneca plc; Novartis AG; Eli Lilly and Company; Celgene Corporation; Gilead Sciences Inc.; Biogen Inc.; Vertex Pharmaceuticals Incorporated; Regeneron Pharmaceuticals Inc.; Alexion Pharmaceuticals Inc.; Incyte Corporation; Seattle Genetics Inc.
Get The Full Global Oncologists Market Report
AIOps Oncologists Market Overview
Oncologists refer to a type of healthcare practitioner who is specialized in the diagnosis and treatment of cancer. Oncologists evaluate the patient, diagnose the cancer, and recommend treatments. They are employed in the treatment and care of cancer patients.
Oncologists Global Market Report 2023 provides data on the global oncologists market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The oncologists market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.